Common Sense Medicine

<p><strong>Welcome back to Common Sense Medicine! </strong>This is a great interview with a physician who is working in the intersection of the care navigation space. Patient-centered care can mean a lot of things to a lot of people. For me, it means that patients are heard in their care journeys and feel as though they have agency in a system which is often confusing and not at all “human-centered.” My guest today is trying to change that through providing a better solution care navigation in cancer care. </p><p>Dr. <a target="_blank" href="https://www.linkedin.com/in/hillarylin/">Hillary Lin</a> is a Stanford-trained, board-certified internal medicine physician and the Co-founder and CEO of <a target="_blank" href="https://www.joincurio.com/">Curio</a>, a HealthTech startup addressing health equity and outcomes via Al-enabled navigation. </p><p>Dr. Lin has contributed to neuroscience and oncology with her peer-reviewed research work. She is a frequent speaker and advisor for programs, including Headstream Innovation and Cornell BioVenture eLab. In her personal life, she enjoys immersive experiences and has completed over 200 escape rooms worldwide.</p><p>Video Version</p><p>[00:59] Hillary’s background in medicine, and Curio’s start </p><p>* She entered medicine because she was passionate about the “human experience,” she knows how complicated life can be and how important health is </p><p>* It’s about all of the aspects around health that you also have to manage when you are sick and not just the disease itself</p><p>* There’s too much focus on the facts of medicine and the facts of biology and it sucked out the “soul” of medicine for her </p><p>* We’re asked as physicians to remember more facts and be computers rather than a person to help guide the journey (AI can help here)</p><p>* Drove her to specialize in oncology because she wanted to be deep in the process of answering existential questions, but when she got there she found out it’s mostly running in and out of bedrooms and clinic rooms. She was trained in internal medicine at Stanford and then went to Columbia for a brief time in an Oncology fellow role</p><p>* You don’t get time to sit down with the patient that much</p><p>* She found that she wasn’t answering the existential questions she wanted to, so she went to digital health innovation and sampled the smorgasbord of what she could be doing, and finally she landed on cancer care navigation</p><p>[06:16] What is so compelling about care navigation for patients? </p><p>* Took her a long time, she was seeking for years to land in a field to innovate in</p><p>* In the beginning, as a relatively new founder, like many founders, she went straight to where the problem was—when founders do this, they try and create a tech-enabled clinical platform for whatever they want to solve quickly. She thinks this is the first-order solution, rather than the final state</p><p>* They found that with more serious healthcare concerns, a lot of it comes down to navigation problems / concerns. Health literacy, access, and equity are prevalent in the U.S. where we have a convoluted system. It’s very hard for them to get optimal treatment and care</p><p>[08:44] All about Curio—what is it & how does it help their end customers? </p><p>* <strong>Problem they’re solving: </strong>Help patients get the resources they need in order to optimize their health </p><p>* The tooling behind that (which is growing) is vast, and it’s growing in real time <strong>Shree’s note: </strong>the tooling now may be different then when we recorded this podcast in November 2023</p><p>* One example of a tool is a natural language parsing tool to provide the opportunity to explain a problem and can connect to a in-person navigator to find those services, or use the AI to find them a personalized service which can help them find the solution for their specific issue </p><p>* The next level of that is to guide them through the steps to get the resources that they need. Instead of having a case manager or a social worker on the line, they can use the AI to navigate the next level </p><p>* The key thing to understand is a <strong>B2B</strong> company which works with health delivery platforms, non-profits, patient support services, and similar entities. 80-90% of the time, there is a human in the loop, such as a social worker or another personnel</p><p>* Rather than focusing on just a patient assistance program in a specific zip code, you can use Curio to add additional parameters (i.e., age, family members, etc.) to add greater “precision level resourcing” for cancer patients</p><p>* There’s also a level of communicative support which uses generative AI to help individualize to the patient’s health literacy level in an SMS or email communication</p><p>[14:35] What are patients most using Curio for? </p><p>* Financial assistance is by far the largest problem which patients face with a cancer diagnosis, and financial toxicity is the main focus of <a target="_blank" href="https://cancerx.health/">Biden’s Cancer X</a> initiative</p><p>* It takes up to 80% of people’s bandwidth and mindshare. Cancer care is so incredibly expensive that people max out their deductible pretty quickly. There’s also legal type of concerns especially with their employers (i.e., leaves of absences)</p><p>* In an earlier rendition, Curio was a mental healthcare company. They found that for cancer care, mental health is a secondary concern, after people are able to pay for their medications and their base needs. There are a lot more resources to tackle mental health than other issues though</p><p>[18:12] Curio’s business model </p><p>* They sell to intermediaries, navigation and utilization discovery services. The ecosystem has become very bloated with point solutions for digital health that benefits administrators get burned out</p><p>* <strong>Shree’s take</strong>: Curio is really trying to differentiate their navigation solution based on its personalization through partnerships. For example, if you have a MSK issue, Curio will basically tell you which piece of education you need to read for your particular issue</p><p>* They use both human / automated version of finding those resources, but they prefer a partnership because then it is more intricately tied to the experience of navigating care</p><p>* They use a tiered utilization pricing model for Curio’s care navigation solutions. They align well for utilization based pricing model because sometimes there’s very low utilization of those benefits </p><p>[27:16] What do oncologists think about this tool? </p><p>* Trust is key to get buy-in from various providers. They are trying to establish strong relations with patient advocacy groups—this is not to just have their logo on their website, but to have relationships with them </p><p>* Hospitals don’t reimburse for care navigation services, so it’s pretty awesome to see that patients are getting these services outside the hospital. Doctors don’t get paid (RVUs) based on them helping the patient navigate the system; social workers are strapped for their time. If patients find Curio or another tool, it can be a real game changer for them</p><p>* They are also working on the pharma side where they are focused on getting patients more adherent onto their treatment, and focusing on patient engagement. Pharma companies want to know why patients aren’t continuing on their treatment (i.e., copay, adverse events, etc.) so it’s actually pretty helpful for them to understand where in the patient journey they are losing the consumer</p><p>[32:49] Does Curio help with finding second opinions? </p><p>* They work with advocacy groups to help find second opinions for their patients. In fact, in Hillary’s opinion, a lot of doctors do value second opinions and look to get them from academic institutions (i.e., you have one oncologist at an academic institution and one in a community setting) </p><p>* They are working on getting a database for clinical trials so patients can use that to find trials which are very helpful to them. Patients are very skeptical of trials, so according to her, getting patients there is 90% of the issue</p><p>* A lot of the convincing happens at the education level and the risks and benefits of the trial</p><p>[40:16] What is different about Curio? </p><p>* <strong>Shree’s note</strong>: I read an market map of the <a target="_blank" href="https://aicheckup.substack.com/p/where-generative-ai-meets-healthcare">Generative AI in healthcare space</a>, where they talked about how the care navigation space is becoming crowded—so I asked Hillary about her opinions in the care navigation niche</p><p>Navigation companies, such as Navvi Health, Collective Health, Auxa, and Talktomira, focus on helping employees and patients navigate their healthcare benefits and options. However, these companies face challenges like overcoming vendor fatigue and budget constraints in the current economic climate. Interestingly, these companies have the largest amount of funding in this category and the lowest amount of median funding per company, which implies the category is more saturated and less capital intensive then other patient-facing categories. We’re excited to see how generative AI can streamline user experiences, interpret health information, and guide patients more holistically, potentially reducing readmissions and encouraging proactive care.</p><p>* Curio is good at <em>patient engagement</em>, which a lot of digital health companies have not been successful at (according to Hillary)</p><p>* Each product / feature release has to be laser-focused on that particular use case—they are trying to solve problems with technology rather than with humans </p><p>* A lot of care navigation companies are human first, with technology enablement, where she thinks it has to be reversed—tech first, with human enablement at points, so that it can scale</p><p>* Now with generative AI, this scalable solution is now possible</p><p>[45:48] What is the future of Curio? </p><p>* They are trying to provide a broader layer of tech for the vision of healthcare—a human person is more than their disease, so they have to have a broad way to access that care </p><p>* Rather than becoming verticalized, they want to go more horizontal—focus on nutrition, wellness, or other places</p><p>[47:04] Why go into Digital Health? </p><p>* It took her years to get her legs underneath her as an entrepreneur. She believes we’re living in a world where healthcare is stuck in an outdated mode of manual labor</p><p>* Looking very closely at other industries, all other industries are moving towards this idea of personalization, but why can’t we focus that on scaling up healthcare for a lot more people? </p><p></p> <br/><br/>This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.shreenadkarni.com?utm_medium=podcast&#38;utm_campaign=CTA_1">www.shreenadkarni.com</a>

<p><strong>Welcome back to Common Sense Medicine! </strong>This is the last post of the year, moving into the holidays, so wishing you happy holidays and a happy new year. </p><p>In this episode, I’m joined by <a target="_blank" href="https://twitter.com/stuartblitz?lang=en">Stuart Blitz</a>, who is the Co-Founder and Chief Operating Officer at <a target="_blank" href="https://honehealth.com/">Hone Health</a>, a men's optimization clinic that offers at-home blood tests, tele-health consultations, and medication delivery. </p><p>Prior to this, Stuart held the position of Chief Business Officer at Seventh Sense Biosystems (now <a target="_blank" href="https://yourbiohealth.com/en-us/news-and-press-releases/seventh-sense-biosystems-unveils-new-name-yourbio-health-raises-21m-funding-to-help-fuel-growth">YourBioHealth</a>), where they played a key role in designing and developing the world's first push-button blood collection device. Before that, they worked at <a target="_blank" href="https://agamatrix.com/">AgaMatrix</a>, where they served as the Executive Director of Business Development and Strategy, as well as the Director of Worldwide Commercial Development. </p><p>Stuart's experience spans over several years and includes a focus on improving healthcare systems and providing convenient solutions for consumers.</p><p>Check out the episode on <a target="_blank" href="https://open.spotify.com/show/5w7QDZgCoe8qaNPOFs0W1U?si=3600930e8b4741d8">Spotify</a>, <a target="_blank" href="https://podcasts.apple.com/us/podcast/common-sense-medicine/id1347470621">iTunes</a>, or <a target="_blank" href="https://www.youtube.com/user/sgndkn">YouTube</a></p><p><p>If you’ve been forwarded this email and are just getting this for the first time— <strong>thanks for reading! I publish podcasts monthly and I’d love for you to subscribe using the link below.</strong></p></p><p>Video Version</p><p><strong>[1:00] Stuart’s origin in HealthTech, and how he created the first-ever medical device for the original iPhone</strong></p><p>* Started his career and joined two founders who started AgaMatrix in the diabetes space</p><p>* He had done Biomedical Engineering in college at Johns Hopkins, and he was sort of the “black sheep” there because people didn’t want to go to health startups in 2002, but rather medical school or government or research</p><p>* AgaMatrix made glucometers with test strips for diabetes and then launched a medical device company </p><p>* They ended up getting to retail pharmacies, and 15 years later the device that they made is still on the shelves at CVS, Krogers, etc. </p><p>* They started working with Apple in 2007, right around the release of the first iPhone, to create a smart glucometer which was cleared by the FDA</p><p>* They were able to partner with Sanofi, and distributed their product in 20-30 countries</p><p><strong>[4:22] Why he decided to stay at AgaMatrix for 10+ years</strong></p><p>* Every 2-3 years, he did something new, so it didn’t feel like that long </p><p>* The first couple years were core startup mode to figure out product-market fit and raise capital. </p><p>* The first idea was to make software to make glucometers work better. This was a stupid idea because people make money on the glucose test strips and not the glucometer themselves</p><p>* The next few years were about growing and selling, and they signed a bunch of deals to distribute their products. One was Liberty Medical, which provided products to people on Medicaid</p><p>* The last few years were about distribution, building around new partnerships like the international one with Sanofi and scaling their sales team to get into more patients’ daily routines</p><p><strong>[7:07] How did he pivot to SeventhSense Bio? </strong></p><p>* He had a lot of experience in HealthTech and diagnostics, and had met SeventhSense Bio before joining them</p><p>* They had an interesting angle on at-home testing, which would require an easy device to get that blood from the patient without the assistance of a healthcare professional</p><p>* Met many founders (ex. Hims, Romans, and also the much-maligned Theranos) and saw the D2C angle for medications</p><p>* Key insight was they haven’t gotten to mass adoption because of cost angle, usability angle, and lab compatibility angle</p><p>* Most important is the usability angle, because at-home diagnostic has to function 99% of the time, the first time (there are no “re-dos” because it isn’t like the patient has another tube or a professional to help them at home). The devices that are on the market right now aren’t there yet, but might get there</p><p>* His thesis was that there are going to be way more D2C, cash-pay, access companies started but they’re going to get started around high-niche customers who aren’t getting serviced already by the system</p><p>[11:39] Founding Hone Health</p><p>* He met his current <a target="_blank" href="https://www.forbes.com/sites/eshachhabra/2022/10/31/one-entrepreneur-turns-his-own-health-journey-into-a-startup-for-mens-hormonal-health/?sh=9fb2956bbfb2">co-founder</a>, <a target="_blank" href="https://honehealth.com/edge/podcast/hone-in-saad-alam/">Saad</a>, and liked his story. Saad had turned 35 and he had all the symptoms of Low Testosterone (Low T)</p><p>* Saad approached Stuart in his role at SeventhSense Bio and thought that his at-home device could help measure low T in his customers</p><p>* Stuart said it might not work that way, but he was intrigued by the business model and decided to join Saad at Hone Health 4 years ago</p><p>[13:23] What does he think was core to build Hone? </p><p>* <strong>Shree’s take:</strong> With D2C companies, I see three issues — the patient needs to know that they have the disease, they need to know where to go to treat it, and they need to make sure that the provider also knows how to treat this under-serviced condition</p><p>* Something that was core to the offering that they built was through building their physician network. A lot of HealthTech companies would use Wheel or SteadyMD provider networks to get started, but the specialty care that Hone provides prevented them from doing this</p><p>* Stuart can tell if the physician is knowledgable about treatment for male hormonal health in 1 minute — do they (1) know the patient population, (2) do they know the protocols around dosing testosterone, (3) are they committed to the clinic by responding frequently / giving this the seriousness that it deserves, (4) can you use technology well to treat patients, and (5) do they pass the vibe check. Below is a video of his real time reaction when a doctor says they don’t know the correct dosing of testosterone</p><p>* Hone’s business model is that a physician meets with a patient after they get labs via a tele-medicine consult, and then they determine based on AUA guidelines whether a patient needs to get low T. Then, the patient gets on a subscription plan to pay for the treatment and has a consult every 90 days</p><p>[21:54] Risks to Hone’s business model by using telemedicine with controlled substances</p><p>* <strong>Context</strong>: The Ryan Haight law prevents providers from using telehealth from prescribing controlled substances. It was temporarily waived during the pandemic, when people needed them to continue on treatment (think Suboxone for opioid dependance, or Testosterone like in this case)</p><p>* Stuart doesn’t think it will be a big risk because the law originally was meant to prevent people from googling “Vicodin” to buy it online. This law came out 15 years ago when telemedicine was far from prevalent</p><p>* The DEA had a proposal (summarized by Stuart) that said that a patient should see a provider in person at least once in 90 days to continue on that prescription for the controlled substance. Hone’s patient population would be OK seeing a practitioner, Stuart thinks, because they go to LabCorp every 90 days for a lab test to continue being on Testosterone</p><p>* The DEA held sessions in September 2023 to learn more about what to do about this restriction, and they decided to make a special registration process to make sure that providers could be able to continue to prescribe controlled substances via a telemedicine pathway which (he thinks) will be finished by the end of next year (2024)</p><p>[27:11] Surprising things that Stuart learned about the patient population at Hone</p><p>* Patients want options, it’s not about either getting labs taken at-home or in the clinic, but it’s the option of getting it at one or the other. You could have a patient in a city who has LabCorp 10 minutes away from them, or a rural area where they have one 150 miles away </p><p>[29:01] Hone Health’s Unit Economics</p><p>* Stuart thinks that Unit Economics have to work from day one, and that VC-backed companies cannot stay afloat if this basic tenet is not met because simply relying on growth will not outpace profitability</p><p>* They want to expand to longevity, thyroid care, obesity, etc. Right now, they don’t serve that and their providers will send them elsewhere to get that care</p><p>[31:20] Stuart’s hot takes on Twitter </p><p>* Stuart thinks that there are many players in the space who are making money off of the “bad things” that are happening in healthcare. If you insert X thing here, and you ask “why isn’t anyone disrupting this? It’s terrible for patients,” there’s probably someone profiting off of that</p><p>* Hone Health might have some competition as more clinics pop up, and there is a “race to the bottom” as they compete on pricing, but they can compete on the value that they provide to the consumer</p><p>* One of the key learnings that they had on Hone Health was that in order to keep OpEx low, they have to be scrappy. Stuart mentioned if you’re starting out, just “use Google Sheets.” Then you can figure out how to get your first customers, and then build from there</p><p>* Those learnings are very critical and they can serve the business </p><p>[38:53] Building their own HIPAA compliant EMR </p><p>* They are not serving a population which requires Meaningful Use metrics (i.e., Medicare), since they are out-of-pocket / cash pay for all of their costs, but if they were then they will add on compliance after the fact </p><p>* They first got one off-the-shelf, but it was pretty bad and wasn’t helpful. The off-the-shelf EMR was fine for doctors who were writing notes, but the problems came in from a product standpoint, where there weren’t meaningful ways to onboard patients and have a good patient journey</p><p>* This was complemented because each of the founders had their own expertise, so they were able to build a better company by having a lot of synergies (marketing, finance, ops, marketing, brand, etc.) </p><p>[43:48] Stuart’s vision for the future of Hone Health </p><p>* At a minimum, they want to be able to network with payers. They want to reduce out-of-pocket costs for patients, and they want to expand the amount of benefits which they can tackle using Hone (i.e., longevity, etc.) </p> <br/><br/>This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.shreenadkarni.com?utm_medium=podcast&#38;utm_campaign=CTA_1">www.shreenadkarni.com</a>

description overflow, removed

<p><strong>Welcome back to Common Sense Medicine! </strong>For the post, skip down ~2 scrolls</p><p><em>Long time, no see</em>, you say. Well, that’s true. I’ve been busy and not-so-busy these past few years, and the long overdue post about “<em>where have you been, Shree?</em>” is coming—I promise. But first, a reflection. Since 2018, when I started this show, the world of healthcare, and my own perspective about it, has changed tremendously. However, there is one constant: talking to people who are “in the weeds” (to borrow a corporate phrase) of the work is the best way to get up to speed in the space. </p><p>There is so much happening in the world of healthcare like Generative AI, electronic health records, and biotech, and I want to write more about all of it. As I’m in a more “chill” part of medical school, I’ve been taking the time to talk to founders of interesting HealthTech startups to build a framework about where the industry is headed.</p><p><em>When can I expect more posts?, </em>you say. First of all, I’m not sure anyone is asking for <em>more</em> emails in their mailbox, but I hope that if you’re subscribed, I’m providing some value. I’m not trying to clutter your email—I think there’s a space for interesting conversations about healthcare around 1 time a month. Plus, most people just skim anyway so I’ll try and keep the show notes and insights on the shorter side. Alright, now that I’ve gotten the niceties over with, here are the show notes.</p><p><p>Forwarded this email? Subscribe below for musings about healthcare conversations with people who are much smarter than me.</p></p><p>What is Anja Health? </p><p><a target="_blank" href="https://www.anjahealth.com/">Anja Health</a> is a health and technology company that provides cord blood, cord tissue, and placenta banking. They are one of the few companies in the world that offer these services. Anja Health's services include: </p><p>* Freezing <strong>umbilical cord and placenta stem cells</strong></p><p>* Sending a kit to <strong>soon-to-be parents in preparation for their birth experience</strong></p><p>* Safely collecting and storing your baby's stem cells for future cell treatments</p><p>* Providing an easy to use collection kit with FDA-approved materials</p><p>* Manual lab processing for maximum stem cell volume</p><p>* <strong>20 years of secure cryogenic storage at -180°C</strong></p><p>* <strong>Personal support from a banking or birth expert</strong></p><p>Anja Health's mission is to create one more treatment option through the power of stem cells. Anja Health was founded by <a target="_blank" href="https://www.tiktok.com/@kathrynanja?lang=en">Kathryn Cross</a>, just over a year after graduating from Wellesley. Kathryn shared her personal story of founding the company in memory of her brother Andrew, who was diagnosed with cerebral palsy after a near-death accident with me on Common Sense Medicine, and below is a summary of our conversation. </p><p>Show Notes (with timestamps)</p><p>* <strong>[00:02:18] Cord blood stem cell space.</strong></p><p>* Kathryn talks about a <a target="_blank" href="https://www.sciencedirect.com/science/article/pii/S0006497118479049">Duke University study</a> which was a randomized, double-blind crossover trial on cerebral palsy (CP) treatment with autologous cord blood (CB). It didn’t show statistically significant results between the study and control groups, but a significant difference was found between the group that received infusions with a higher dose of (>2.5 * 10^7 cells) versus those who did not. </p><p>* Providers historically have not been educated about giving information about cord blood banking, and social media is easier to go direct to the customer to educate them about the cord blood banking. She spoke about creator-led businesses, which have greater trust (especially in the beginning) when they have <a target="_blank" href="https://news.thepublishpress.com/p/sarah-renae-clark-monetized-small-art-community">relatability and value capture</a> on their side. This was the enabling factor to gaining and acquiring their first few customers. </p><p>* <strong>[00:07:45] Lessons from team members.</strong></p><p>* She was a younger founder, and she needed to read a lot of material around management to “learn the ropes.” She touches each part of business, but she has been decreasing her involvement with ops to focus on growth and marketing. She tried to find someone who is better than she is at parts of the business, and then aligning with them to achieve the goals which she has for Anja. </p><p>* <strong>[00:11:19] Fundraising process and mistakes.</strong></p><p>* Kathryn talked about using a process to fundraise for a startup using Ryan Breslow’s book <a target="_blank" href="https://www.amazon.com/Fundraising-Ryan-Breslow/dp/B09CR7TFDT">Fundraising</a>. He recommends to only fundraise for 3 months, and make sure that you don’t fundraise too early before you have product-market fit because the growth will be very painful if so. Kathryn thought that she fundraised too early, and this was partly because she didn’t have a process going into her fist fundraising round. </p><p>* <strong>[00:15:17] Private blood banking - why should parents use it?</strong> </p><p>* Kathryn says that most pregnant people should be using cord blood banking because the placenta and the cord blood bank can act as a sort of “insurance” against a worst case scenario. Physicians can use stem cells to prepare treatment and then Anja Health is able to release a patient’s units to the provider, and then it’s used to give the patient the stem cell treatment. </p><p>* <em>Shree’s take</em><em>: </em>I’m not convinced that doing this by way of a private blood bank vs. a public blood bank is still reasonable in this day and age, because the cost doesn’t justify the evidence which is currently available. If you’re bullish on storing on a private blood bank, look for one which is AABB accredited (by the FDA, like Anja is). The one drawback from a public bank which I had noticed is that you might not get your cells if someone else had already used it, but looking at the Duke University study and others in the space, the blood collected<a target="_blank" href="https://www.cryo-cell.com/cord-blood-treating-diseases"> might not be useful</a> if you only have one child to do an autologous stem cell transplant—as most of the research is done in preclinical models. However, that’s part of Anja’s allure, because you <em>might</em> be able to use it in the next 20 years for therapies which haven’t been discovered today. </p><p>* <strong>[00:24:24] Using placenta stem cells.</strong></p><p>* When someone actually donates a blood bank sample, they can increase the density by first sorting it manually. Anja Health mentions that they can do it manually but other companies say that the automatic sorting helps them get rid of contaminants.</p><p>* <em>Shree’s take</em><em>: </em>I think that this is a function of marketing—if Anja Health is able to capture more of the market and convince their buyers that automatic sorting = bad, and that manual sorting = personalized, then they can effectively control the narrative that their method is better. Kathryn also mentions that she doesn’t have any statistics about how many people actually <em>use</em> their stem cells, which gives me pause. How useful could this be if people aren’t using it and it’s mostly a function of marketing? In fact, <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022688/">one paper</a> shows that automatic sorting actually increases the yield of the cord blood separation. </p><p>* <strong>[00:28:05] Stem cell research in pregnancy.</strong></p><p>* She’s excited about more general parts of women’s health related work — infertility and PCOS which came to mind. She also thinks that you <strong>shouldn’t consume your placenta</strong>, ya nasty. </p><p>* <strong>[00:29:24] Scaling content and creator burnout.</strong></p><p>* It’s really hard to scale content because there’s a threshold to how much content you can produce. She batches a lot of content, but it’s hard to scale them. She had a consigliere who fed her research about content, but now she just does her own thing. She also interviews a lot of people in the space, like doulas, midwives, and lactation consultants. Kathryn thinks that now, she’s more able to do speak about her interests “off the cuff” because she’s just had so much experience in the space. </p><p>* <strong>[00:34:07] Consuming information and deciphering.</strong></p><p>* Interestingly she says that lower-income families do a lot more research, read everything, and are more anxious with childbirth rather than those who come from a higher-income family. So, she tries to recommend evidence-based organizations to help families distinguish signal from noise. </p><p>* <strong>[00:36:00] Recruiting. </strong></p><p>* She’s still figuring out how to best recruit, but one of the things that she has to do in order to really put herself in a position for recruiting the best talent is to interview the person and make sure they gel with everyone on the team, whether they have the skills for the particular role that she’s hiring for, and gradually hiring into the role (contractor to employee)</p><p>* Another book from Ryan Breslow which she recommends is <a target="_blank" href="https://www.amazon.com/Recruiting-Ryan-Breslow/dp/B09NGVLQ8W">Recruiting</a></p><p>* <strong>[00:45:57] Favorite guest and learning experiences.</strong></p><p>* Kathryn’s question for me! Listen to the podcast to learn more. </p><p>Thank you for subscribing to Common Sense Medicine! If you have any comments / questions, please reply to this email to let me know what you think. </p><p><strong>Also, I’m also on the hunt for new podcast guests. If you know anyone who you think would be a good fit (think people in healthtech or healthcare doing interesting, innovative things) feel free to let me know. </strong></p><p>That’s all folks! Remember, it’s just common sense. </p><p>— Shree “I will never eat a placenta” Nadkarni</p> <br/><br/>This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.shreenadkarni.com?utm_medium=podcast&#38;utm_campaign=CTA_1">www.shreenadkarni.com</a>

is a 4th year physical medicine and rehabilitation resident physician and will begin a sports medicine fellowship this summer. He is also a YouTuber with nearly 450,000 subscribers on his channel where he provides educational videos about sports...